CAM
SPPI

Cresset Asset Management’s Spectrum Pharmaceuticals Inc SPPI Stock Holding History

Cresset Asset Management’s Portfolio SPPI Stock Details SPPI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-88
Closed -$1K – 1855
2019
Q1 		$1K Buy
+88
New +$942 ﹤0.01% 1919

Other funds holding SPPI

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Cresset Asset Management's SPPI Position: Q2 2019 in Review

Cresset Asset Management sold out of Spectrum Pharmaceuticals Inc (SPPI) in Q2 2019, closing a stake of 88 shares — an estimated $1K sold.

Cresset Asset Management first reported a position in SPPI in Q1 2019 and held it in 1 quarter. The position peaked at $1K in Q1 2019. 165 funds tracked by Wall St. Rank hold SPPI as of Q2 2019.

  • Cresset Asset Management reported no remaining Spectrum Pharmaceuticals Inc position as of Q2 2019 after selling out during the quarter.
  • Cresset Asset Management sold 88 Spectrum Pharmaceuticals Inc shares in Q2 2019, an estimated $1K.
  • Cresset Asset Management first reported a position in Spectrum Pharmaceuticals Inc in Q1 2019 and held it in 1 quarter.
  • Cresset Asset Management's Spectrum Pharmaceuticals Inc position peaked at $1K in Q1 2019.
  • 165 funds tracked by Wall St. Rank held Spectrum Pharmaceuticals Inc as of Q2 2019.

Based on Cresset Asset Management's 13F filing for Q2 2019, filed 12 Aug 2019.